Retour
Fourchette du Jour
65,94 €
69,02 €
Fourchette 52 Semaines
35,95 €
87,50 €
Volume
827 329
Moyenne 50J / 200J
70,95 €
/
63,75 €
Clôture Précédente
65,30 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 8,1 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,8 |
| Net Margin % | 39,4 | 3,9 |
| Rev Growth 5Y % | 33,9 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
84,50 €
+27.2%
Low: 50,00 €
High: 120,00 €
BPA Prévisionnel
-0,69 €
CA Est.
960 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
4,88 €
3,53 € – 6,30 €
|
1,7 B | 2 |
| FY2029 |
4,12 €
2,98 € – 5,32 €
|
1,6 B | 4 |
| FY2028 |
1,47 €
-3,92 € – 8,37 €
|
1,4 B | 6 |
Points Clés
Revenue grew 33,89% annually over 5 years — strong growth
Net margin of 39,44% shows strong profitability
Generating 702,34M in free cash flow
P/E of 8,05 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 80,62%
Cash machine — converts 102,88% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
33,89%
Revenue (1Y)114,51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROIC223,85%
Net Margin39,44%
Op. Margin49,49%
Sécurité
Debt / Equity
N/A
Current Ratio2,35
Interest Coverage5,63
Valorisation
P/E Ratio
8,05
P/B RatioN/A
EV/EBITDA5,84
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 114,51% | Revenue Growth (3Y) | 35,85% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33,89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,73B | Net Income (TTM) | 682,64M |
| ROE | N/A | ROA | 23,45% |
| Gross Margin | 95,85% | Operating Margin | 49,49% |
| Net Margin | 39,44% | Free Cash Flow (TTM) | 702,34M |
| ROIC | 223,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,35 |
| Interest Coverage | 5,63 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 8,05 | P/B Ratio | N/A |
| P/S Ratio | 3,18 | PEG Ratio | -0,03 |
| EV/EBITDA | 5,84 | Dividend Yield | 0,00% |
| Market Cap | 5,50B | Enterprise Value | 5,01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,73B | 806,78M | 937,82M | 698,80M | 538,59M |
| Net Income | 682,64M | -363,30M | -626,60M | -559,02M | -523,90M |
| EPS (Diluted) | 7,78 | -4,73 | -8,37 | -7,79 | -7,43 |
| Gross Profit | 1,66B | 749,38M | 872,34M | 654,12M | 506,27M |
| Operating Income | 856,51M | -302,57M | -439,50M | -447,41M | -374,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,91B | 1,71B | 1,90B | 1,71B | 1,94B |
| Total Liabilities | 3,12B | 2,80B | 2,71B | 2,05B | 1,94B |
| Shareholders' Equity | -205,31M | -1,10B | -818,56M | -347,09M | 1,44M |
| Total Debt | 492,28M | 2,47B | 2,23B | 1,46B | 1,27B |
| Cash & Equivalents | 984,65M | 779,71M | 594,00M | 279,83M | 189,72M |
| Current Assets | 2,27B | 1,37B | 1,22B | 693,79M | 954,37M |
| Current Liabilities | 968,43M | 580,98M | 603,10M | 406,24M | 509,35M |